Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
J&J vets burst into biotech with $165M Third Arc series A
Fierce Biotech
Tue, 07/23/24 - 11:22 am
JNJ
Third Arc Bio
funding
solid tumors
autoimmune disease
J&J seeks expanded approval for antidepressant Spravato
BioPharma Dive
Mon, 07/22/24 - 06:43 pm
JNJ
depression
Spravato
J&J drops Addex-partnered epilepsy drug after reviewing failed phase 2 trial data
Fierce Biotech
Thu, 07/18/24 - 11:20 am
JNJ
Addex Therapeutics
epilepsy
ADX71149
Janssen
Medtech firms have cut more than 14,000 jobs in the past 18 months
Medtech Dive
Thu, 07/18/24 - 11:14 am
Medtech
layoffs
diagnostics
Thermo Fisher
JNJ
GeneDx
Baxter
Abbott Labs
Cardinal Health
Becton Dickinson
Intuitive Surgical
J&J, BMS and AstraZeneca strike back in appeals after IRA litigation losses
Fierce Pharma
Tue, 07/16/24 - 12:00 pm
Inflation Reduction Act
Medicare
drug pricing
JNJ
Bristol Myers Squibb
AstraZeneca
Johnson & Johnson proposes $505M settlement with bankrupt talc miners
Fierce Pharma
Tue, 07/16/24 - 11:59 am
JNJ
legal
J&J agrees to slash Sirturo price in South Africa, prompting authorities to end antitrust probe
Fierce Pharma
Tue, 07/9/24 - 09:17 pm
JNJ
legal
Sirturo
South Africa
tuberculosis
antitrust
The battle over J&J’s bankruptcy plan to end talc lawsuits
Reuters
Tue, 07/9/24 - 11:59 am
JNJ
legal
bankruptcy
Emergent, J&J settle COVID vaccine supply deal dispute
Reuters
Mon, 07/8/24 - 10:59 pm
JNJ
Emergent BioSolutions
vaccines
COVID-19
legal
J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma
Fierce Pharma
Tue, 07/2/24 - 11:22 am
JNJ
Legend Biotech
CAR-T
Carvykti
Multiple Myeloma
clinical trials
Samsung Bioepis Gets FDA Approval for Biosimilar of J&J’s Stelara
BioSpace
Mon, 07/1/24 - 09:58 pm
Samsung Bioepis
FDA
Pyzchiva
biosimilars
JNJ
Stelara
J&J unwraps pivotal data on $6.5B autoimmune asset as it prepares to crash argenx and UCB's party
Fierce Biotech
Mon, 07/1/24 - 11:23 am
JNJ
nipocalimab
myasthenia gravis
clinical trials
UCB
Argenx
Cancer victims lose bid to block proposed J&J talc bankruptcy
Reuters
Sun, 06/30/24 - 09:49 pm
JNJ
legal
bankruptcy
cancer
Despite J&J's Rybrevant full nod, FDA encourages Dizal to file rival lung cancer drug for accelerated approval
Fierce Pharma
Thu, 06/27/24 - 10:08 pm
JNJ
Rybrevant
Dizal Pharma
FDA
non-small cell lung cancer
How Pfizer, Bristol Myers Squibb and Johnson & Johnson Are Confronting Patent Cliffs
BioSpace
Wed, 06/26/24 - 09:54 am
patents
Pfizer
Bristol Myers Squibb
JNJ
patent cliffs
J&J’s Blockbuster Tremfya Flops in Phase II Giant Cell Arteritis Trial
BioSpace
Tue, 06/25/24 - 11:33 am
JNJ
Tremfya
clinical trials
giant cell arteritis
Supreme Court gives pharma giants another chance to sidestep terrorism-funding case
Fierce Pharma
Mon, 06/24/24 - 10:08 pm
legal
AstraZeneca
GE Healthcare
JNJ
Pfizer
Roche
terrorism
J&J MedTech Launch Polyphonic Digital Surgical Ecosystem
Medtech Dive
Thu, 06/20/24 - 05:59 pm
Medtech
JNJ
Polyphonic
digital surgical ecosystem
J&J to seek appeal of $150M verdict in long-spanning HIV meds off-label marketing case
Fierce Pharma
Mon, 06/17/24 - 10:31 pm
JNJ
Janssen
off-label
HIV
legal
whistleblower lawsuits
Prezista
Intelence
J&J commits five-year investment in Italian medicine manufacturing
European Pharmaceutical Review
Mon, 06/17/24 - 10:29 pm
JNJ
Johnson & Johnson Innovative Medicine
Italy
drug manufacturing
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »